143 related articles for article (PubMed ID: 1479739)
21. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A
Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537
[TBL] [Abstract][Full Text] [Related]
22. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
[TBL] [Abstract][Full Text] [Related]
23. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
Matsumura Y; Maeda H; Kato H
Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
[TBL] [Abstract][Full Text] [Related]
24. The role of kinin B1 in the plasma extravasation of carrageenin-induced pleurisy.
Hayashi I; Amano H; Ishihara K; Kumagai Y; Yoshimura H; Majima MC
Life Sci; 2002 Jan; 70(8):937-49. PubMed ID: 11853231
[TBL] [Abstract][Full Text] [Related]
25. Isolation and cardiovascular activity of a second bradykinin-related peptide ([Arg0, Trp5, Leu8]bradykinin) from trout.
Conlon JM; Le Mevel JC; Conklin D; Weaver L; Duff DW; Olson KR
Peptides; 1996; 17(3):531-7. PubMed ID: 8735984
[TBL] [Abstract][Full Text] [Related]
26. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats.
Belichard P; Luccarini JM; Defrêne E; Faye P; Franck RM; Duclos H; Paquet JL; Pruneau D
Br J Pharmacol; 1999 Sep; 128(1):213-9. PubMed ID: 10498854
[TBL] [Abstract][Full Text] [Related]
28. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.
Bélichard P; Loillier B; Paquet JL; Luccarini JM; Pruneau D
Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products.
Sheikh IA; Kaplan AP
Biochem Pharmacol; 1989 Mar; 38(6):993-1000. PubMed ID: 2539165
[TBL] [Abstract][Full Text] [Related]
30. Effect of enalaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart.
Lamontagne D; Nadeau R; Adam A
Br J Pharmacol; 1995 Jun; 115(3):476-8. PubMed ID: 7582459
[TBL] [Abstract][Full Text] [Related]
31. Activation of cathepsin B involved in enkephalin production by bradykinin and its cleavage products in cultured fibroblasts of the rat dental pulp.
Zhu BF; Kudo T; Maeda S; Inoki R
J Osaka Univ Dent Sch; 1992 Dec; 32():27-44. PubMed ID: 1341708
[TBL] [Abstract][Full Text] [Related]
32. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
Drapeau G; Audet R; Levesque L; Godin D; Marceau F
J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
[TBL] [Abstract][Full Text] [Related]
33. Kinin-induced prolongation of action-potential duration in right ventricular muscle from rat: involvement of B1 and B2 receptors.
Gouin L; Cardinal R; Adam A; Drapeau G; Nadeau R
J Cardiovasc Pharmacol; 1996 Aug; 28(2):337-43. PubMed ID: 8856493
[TBL] [Abstract][Full Text] [Related]
34. Antagonism of the algesic action of bradykinin on the human blister base.
Whalley ET; Clegg S; Stewart JM; Vavrek RJ
Adv Exp Med Biol; 1989; 247A():261-8. PubMed ID: 2603793
[TBL] [Abstract][Full Text] [Related]
35. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
36. Effects of dexamethasone and protein kinase C inhibitors on the induction of bradykinin B1 mRNA and the bradykinin B1 receptor-mediated contractile response in isolated rat ileum.
Ueno A; Dekura E; Kosugi Y; Yoshimura M; Naraba H; Kojima F; Oh-ishi S
Biochem Pharmacol; 2002 Jun; 63(11):2043-53. PubMed ID: 12093482
[TBL] [Abstract][Full Text] [Related]
37. Antidipsogenic effects of eel bradykinins in the eel Anguilla japonica.
Takei Y; Tsuchida T; Li Z; Conlon JM
Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1090-6. PubMed ID: 11557614
[TBL] [Abstract][Full Text] [Related]
38. Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1.
deBlois D; Bouthillier J; Marceau F
Br J Pharmacol; 1991 May; 103(1):1057-66. PubMed ID: 1878745
[TBL] [Abstract][Full Text] [Related]
39. Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N.
Sheikh IA; Kaplan AP
Biochem Pharmacol; 1986 Jun; 35(12):1957-63. PubMed ID: 3718539
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of bradykinin In vivo in humans: identification of BK1-5 as a stable plasma peptide metabolite.
Murphey LJ; Hachey DL; Oates JA; Morrow JD; Brown NJ
J Pharmacol Exp Ther; 2000 Jul; 294(1):263-9. PubMed ID: 10871321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
